Applications of Encapsulation and Controlled Release (Record no. 70190)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04822cam a2200577Mu 4500 |
001 - CONTROL NUMBER | |
control field | 9780429299520 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20220711212018.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 190921s2019 xx o 000 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781000566925 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1000566927 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9780429299520 |
-- | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 0429299524 |
-- | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781000571783 |
-- | (electronic bk. : Mobipocket) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1000571785 |
-- | (electronic bk. : Mobipocket) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9781000576641 |
-- | (electronic bk. : EPUB) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 1000576647 |
-- | (electronic bk. : EPUB) |
082 04 - CLASSIFICATION NUMBER | |
Call Number | 660/.28 |
245 00 - TITLE STATEMENT | |
Title | Applications of Encapsulation and Controlled Release |
250 ## - EDITION STATEMENT | |
Edition statement | 2nd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication | Milton : |
Publisher | CRC Press LLC, |
Year of publication | 2019. |
300 ## - PHYSICAL DESCRIPTION | |
Number of Pages | 1 online resource (491 p.). |
490 1# - SERIES STATEMENT | |
Series statement | Encapsulation and Controlled Release Ser. |
500 ## - GENERAL NOTE | |
Remark 1 | Description based upon print version of record. |
505 0# - FORMATTED CONTENTS NOTE | |
Remark 2 | Cover; Half Title; Series Page; Title Page; Copyright Page; Dedication Page; Contents; Preface; Editor; Contributors; 1: Multi-Cyclodextrin Supramolecular Encapsulation Entities for Multifaceted Topical Drug Delivery Applications; 1.1 Introduction; 1.2 Cyclodextrin Properties That Confer Suitability in Drug Delivery Applications; 1.3 Types of Multi-Cyclodextrin Entities: Properties and Applications; 1.3.1 Cyclodextrin-Based Polyrotaxanes; 1.3.2 Cyclodextrin-Based Nanosponges; 1.3.3 Cyclodextrin Polymers; 1.4 Approaches to the Production of Cyclodextrins: Synthesis and Derivatives |
505 8# - FORMATTED CONTENTS NOTE | |
Remark 2 | 1.4.1 Cyclodextrin-Based Polyrotaxanes1.4.1.1 Threading Process; 1.4.1.2 Rotaxanation of Pseudopolyrotaxanes; 1.4.2 Cyclodextrin-Based Nanosponges; 1.5 Cyclodextrins and Multi-Cyclodextrins Applied for Topical and Targeted Drug Delivery; 1.5.1 Tissue Surface Applications; 1.5.1.1 Ocular Surface Applications; 1.5.1.2 Oral Cavity and Tooth Surface Applications; 1.5.1.3 Dermal Applications; 1.5.2 Mucosal Membrane Applications; 1.5.2.1 Buccal Mucosa; 1.5.2.2 Sublingual Mucosa; 1.5.2.3 Nasal Mucosa; 1.6 Conclusion; Conflict of Interest; Acknowledgments; References |
505 8# - FORMATTED CONTENTS NOTE | |
Remark 2 | 2: Nanocomplexes for Topical Drug Delivery2.1 Introduction; 2.2 Skin Morphology and Barrier Functions; 2.3 Purpose of Topical Preparation; 2.4 Nanotechnology for the Skin; 2.5 Different Nanocarriers for Topical Delivery; 2.5.1 Nanoparticles; 2.5.2 Nanoemulsions; 2.5.3 Solid Lipid Nanoparticles (SLNs); 2.5.4 Nanostructured Lipid Carriers (NLCs); 2.5.5 Liposomes; 2.5.6 Niosomes; 2.5.7 Dendrimers; 2.6 Delivery of Drugs through Nanocarriers; 2.6.1 Anti-Inflammatory Drugs; 2.6.2 Anti-Photoaging Drugs and Antioxidants; 2.6.3 Antimicrobial Agents; 2.6.4 Anti-Proliferative Agents; 2.7 Conclusion |
505 8# - FORMATTED CONTENTS NOTE | |
Remark 2 | 3.5.3 Initiator Employed for Hydrogels3.5.4 Cross-linkers Employed for Preparation of Hydrogels; 3.5.5 Applications; 3.5.6 Subcutaneous Drug Targeting; 3.5.7 Transdermal Delivery; 3.5.8 Delivery of Growth Factors; 3.5.9 Cancer; 3.5.10 Wound Dressing; 3.5.11 Oral Treatment; 3.5.12 Ophthalmic Delivery; 3.5.13 GIT Targeting; 3.6 Conclusion; References; 4: Polymer-Drug Conjugates as Drug Delivery Systems; 4.1 Introduction; 4.2 Self-Assembly Behavior of Amphiphilic Polymer-Drug Conjugates; 4.3 Self-Assembled Polymer-Drug Conjugates; 4.4 Stimuli-Responsive Self-Assembled Polymer-Drug Conjugates |
500 ## - GENERAL NOTE | |
Remark 1 | 4.5 pH-Responsive Self-Assembled Polymer-Drug Conjugates |
520 ## - SUMMARY, ETC. | |
Summary, etc | The field of encapsulation, especially microencapsulation, is a rapidly growing area of research and product development. Applications of Encapsulation and Controlled Release offers a broad perspective on a variety of applications and processes, including, up-to-date research, figures, tables, illustrations, and references. Written at a level comprehensible to non-experts, it is a rich source of technical information and current practices in research and industry. |
700 1# - AUTHOR 2 | |
Author 2 | Mishra, Munmaya K. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | https://www.taylorfrancis.com/books/9780429299520 |
856 42 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | eBooks |
588 ## - | |
-- | OCLC-licensed vendor bibliographic record. |
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | MEDICAL / Biotechnology |
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | SCIENCE / Chemistry / General |
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | TECHNOLOGY / Material Science |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Controlled release technology. |
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1 | |
-- | Drug delivery systems. |
No items available.